CH d'Annecy — Annecy

Public research footprint of CH d'Annecy, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive · Diffuse Large B-cell Lymphoma · Prefibrotic/Early Primary Myelofibrosis · High-risk Patients

Recently updated registry entries

NCT02896842 — A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate… (Completed)
NCT03943914 — Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed… (Completed)
NCT06062537 — Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CH d'Annecy?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.